In addition, two other clamp studies in type 1 (21) and type 2 diabetes (20) showed that the duration of action of basal insulin analogues was dose-dependent, i.e., higher doses resulted in longer durations of action, as is observed for all insulins and, indeed, for all pharmaceuticals. Here, INS is linked to type 2 diabetes mellitus.